fluorodeoxyglucose f18 has been researched along with Esophagitis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Mamaliga, T | 1 |
| Chen, Y; Liu, H; Tang, W; Xie, Y | 1 |
| Furukawa, D; Kawahara, T; Ohtani, K; Tsutsui, H; Yakabe, D | 1 |
| Brown, RK; Cease, KB; Gross, M; Kong, FM; Schipper, M; Stanton, P; ten Haken, RK; Yu, J; Yuan, ST; Zhao, L | 1 |
| Bradshaw, L; Farukhi, I; Gould-Simon, A; Kaif, M; Lazaga, F; Schmidt, R; Stagg, J; Thompson, C | 1 |
| Kuyumcu, S; Mudun, A; Şanlı, Y; Yeğen, G | 1 |
| Bal, C; Behera, A; Chakraborty, PS; Kumar, R; Mukherjee, A | 1 |
| Becker, N; Bezjak, A; Bissonnette, JP; Clarke, K; Ford, V; Higgins, J; Le, LW; Marshall, A; McCloskey, P; Mehmood, Q; Sun, A; Vines, DC; Yap, M | 1 |
| Briere, TM; Court, LE; Gomez, DR; Liao, Z; Martel, MK; Mohan, R; Niedzielski, JS; Stingo, F; Yang, J | 1 |
| Cheng, KY; Ding, HJ; Kao, CH; Lai, HC; Li, CI; Lin, YY; Tsai, MK; Wang, KB; Yen, KY | 1 |
| Belderbos, J; Kwint, M; Lebesque, J; Nijkamp, J; Rossi, M; Sonke, JJ; Uyterlinde, W; van den Heuvel, M; Vogel, W | 1 |
| Alavi, A; Bhargava, P; Reich, P; Zhuang, H | 1 |
| Bley, TA; Brink, I; Hentschel, M; Imdahl, A; Kleimaier, M; Mix, M; Moser, E; Walch, A | 1 |
| Alavi, A; Aydin, A; Dhurairaj, T; Shrikanthan, S; Zhuang, H | 1 |
| Alia, AG; Amin, T; Bakheet, SM; Kuzo, R; Powe, J | 1 |
15 other study(ies) available for fluorodeoxyglucose f18 and Esophagitis
| Article | Year |
|---|---|
Hypermetabolic Esophagitis Dessicans Superficialis Mimicking Esophageal Cancer on FDG PET/CT.
Topics: Aged, 80 and over; Esophageal Neoplasms; Esophagitis; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Elevated FAPI Activity in Ulcerative Fungal Esophagitis.
Topics: Biological Transport; Diagnosis, Differential; Esophageal Neoplasms; Esophagitis; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2023 |
Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
Topics: Candida albicans; Candidiasis; Esophagitis; Female; Fluconazole; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiographic Image Enhancement; Sarcoidosis; Treatment Outcome | 2017 |
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.
Topics: Aged; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Esophagitis; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Barrett Esophagus; Diagnosis, Differential; Endoscopy, Digestive System; Esophageal Diseases; Esophageal Neoplasms; Esophagitis; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; United States; United States Department of Veterans Affairs | 2015 |
Candida esophagitis mimicking esophageal malignancy on 18FDG PET/CT.
Topics: Candida; Candidiasis; Diagnosis, Differential; Esophageal Neoplasms; Esophagitis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2015 |
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiation Injuries | 2016 |
(18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Detection of gastroesophageal reflux esophagitis using 2-fluoro-2-deoxy-d-glucose positron emission tomography.
Topics: Esophagitis; Female; Fluorodeoxyglucose F18; Gastroesophageal Reflux; Humans; Male; Positron-Emission Tomography | 2012 |
Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.
Topics: Acute Disease; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose-Response Relationship, Radiation; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2013 |
Radiation-induced esophagitis on FDG PET imaging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Esophagitis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Radiotherapy; Tomography, Emission-Computed | 2003 |
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagitis; Esophagus; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Statistics as Topic; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging.
Topics: Candidiasis; Diagnosis, Differential; Esophageal Neoplasms; Esophagitis; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
F-18 FDG uptake in benign esophageal disease.
Topics: Adult; Aged; Barrett Esophagus; Diagnosis, Differential; Esophageal Diseases; Esophageal Neoplasms; Esophageal Spasm, Diffuse; Esophageal Stenosis; Esophagitis; Female; Fluorodeoxyglucose F18; Gastroesophageal Reflux; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |